5 Key Takeaways
-
1
Alcon's Voyager DSLT device for glaucoma is now available in the US, simplifying training and operation with touchscreen control.
-
2
Genentech's Susvimo is the first FDA-approved treatment for diabetic macular edema that maintains vision with fewer injections.
-
3
The FDA approved Izervay's expanded label, allowing more flexible treatment duration for geographic atrophy due to age-related macular degeneration.
-
4
Norlase launched the LYNX laser indirect ophthalmoscope, offering an untethered solution with integrated pattern-scanning capabilities.
-
5
Optos PLC introduced MonacoPro, an upgraded imaging system that enhances diagnostic precision with integrated OCT and automated retinal area measurement.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.